Iris Löw-Friedrich
Algemeen Directeur bij ZOGENIX, INC.
Profiel
Dr. Iris Lw-Friedrich is Vice-Voorzitter-Raad van Toezicht bij Evotec SE, Chief Medical Officer & Executive Vice President bij UCB SA en Professor aan de Johann Wolfgang Goethe-Universitt Frankfurt am Main. Zij zetelt in de Raad van Bestuur van Fresenius SE & Co. KGaA en Evotec SE. Dr. Lw-Friedrich was voorheen werkzaam als Voorzitter bij Transcelerate Biopharma, Inc, als Lid-Raad van Toezicht bij Heidelberg Pharma AG, als Directeur-Research & Development bij UCB Pharma GmbH, als Vice-President-Global Projects bij BASF Pharma, als Vice-President-Global Projects bij BASF AG, als Vice-President-Clinical Development bij Hoechst AG, als Hoofd-Global Clinical Management & VP bij Aventis Pharma AG, en als Vice-President-Clinical Development bij Hoechst Marion Roussel, Inc. Zij behaalde haar doctoraat aan de Johann Wolfgang Goethe-Universitt Frankfurt am Main.
Laatste nieuws over Iris Löw-Friedrich
Actieve functies van Iris Löw-Friedrich
Bedrijven | Functie | Begin |
---|---|---|
UCB | Hoofd Techniek/Wetenschap/O&O | 01-03-2008 |
EVOTEC SE | Voorzitter | 15-06-2021 |
FRESENIUS SE & CO. KGAA | Directeur/Bestuurslid | 13-05-2016 |
ZOGENIX, INC. | Algemeen Directeur | - |
Johann Wolfgang Goethe-Universität Frankfurt am Main | Corporate Officer/Principal | 01-01-2000 |
PhRMA Foundation
![]() PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services PhRMA Foundation engages in research and development of drugs. The non-profit company is based in Washington, DC. | Directeur/Bestuurslid | 01-04-2019 |
Eerdere bekende functies van Iris Löw-Friedrich
Bedrijven | Functie | Einde |
---|---|---|
Transcelerate Biopharma, Inc.
![]() Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Voorzitter | 01-09-2017 |
UCB Pharma GmbH
![]() UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 |
BASF SE | Corporate Officer/Principal | 01-01-2001 |
░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Iris Löw-Friedrich
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
UCB | Health Technology |
HEIDELBERG PHARMA AG | Health Technology |
EVOTEC SE | Health Technology |
BASF SE | Producer Manufacturing |
FRESENIUS SE & CO. KGAA | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
UCB Pharma GmbH
![]() UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
Transcelerate Biopharma, Inc.
![]() Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
Hoechst Marion Roussel, Inc. | Health Technology |
Hoechst AG
![]() Hoechst AG Chemicals: Major DiversifiedProcess Industries Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany. | Process Industries |
Aventis Pharma AG | |
BASF Pharma | |
PhRMA Foundation
![]() PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services PhRMA Foundation engages in research and development of drugs. The non-profit company is based in Washington, DC. | Commercial Services |
Zogenix, Inc.
![]() Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Zogenix, Inc. is a pharmaceutical company. The firm engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include Fintepla and MT1621. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA. | Health Technology |